相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector
Derek Ostertag et al.
NEURO-ONCOLOGY (2012)
Oncolytic viruses and histone deacetylase inhibitors-A multi-pronged strategy to target tumor cells
Thi Lien-Anh Nguyen et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Bone Marrow Mesenchymal Stem Cells Loaded With an Oncolytic Adenovirus Suppress the Anti-adenoviral Immune Response in the Cotton Rat Model
Atique U. Ahmed et al.
MOLECULAR THERAPY (2010)
Targeting Localized Immune Suppression Within the Tumor Through Repeat Cycles of Immune Cell-oncolytic Virus Combination Therapy
Stephen H. Thorne et al.
MOLECULAR THERAPY (2010)
The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell development
Il-Kyoo Park et al.
BLOOD (2009)
Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis
Cai Zhang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Pharmacologic and Chemical Adjuvants in Tumor Virotherapy
Christopher Alvarez-Breckenridge et al.
CHEMICAL REVIEWS (2009)
Efficacy of Systemically Administered Oncolytic Vaccinia Virotherapy for Malignant Gliomas Is Enhanced by Combination Therapy with Rapamycin or Cyclophosphamide
Xue Qing Lun et al.
CLINICAL CANCER RESEARCH (2009)
Anti-leukemic activity of valproic acid and imatinib mesylate on human Ph plus ALL and CML cells in vitro
Brigitte Kircher et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Converting Tumor-specific Markers Into Reporters of Oncolytic Virus Infection
Ianko D. Iankov et al.
MOLECULAR THERAPY (2009)
Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre- and Post-tumor Resection for Recurrent GBM
James M. Markert et al.
MOLECULAR THERAPY (2009)
Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus
Jian Qiao et al.
CLINICAL CANCER RESEARCH (2008)
Prolonged Microglial Cell Activation and Lymphocyte Infiltration following Experimental Herpes Encephalitis
Cristina P. Marques et al.
JOURNAL OF IMMUNOLOGY (2008)
Oncolytic HSV-1 infection of tumors induces angiogenesis and upregulates CYR61
Kazuhiko Kurozumi et al.
MOLECULAR THERAPY (2008)
Histone deacetylase inhibitors augment antitumor efficacy of herpes-based oncolytic viruses
Akihiro Otsuki et al.
MOLECULAR THERAPY (2008)
Trichostatin A and oncolytic HSV combination therapy shows enhanced antitumoral and antiangiogenic effects
Ta-Chiang Liu et al.
MOLECULAR THERAPY (2008)
A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas
Peter Forsyth et al.
MOLECULAR THERAPY (2008)
Exponential enhancement of oncolytic vesicular stomatitis virus potency by vector-mediated suppression of inflammatory responses in vivo
Jennifer Altomonte et al.
MOLECULAR THERAPY (2008)
Oncolytic herpes virus with defective ICP6 specifically replicates in quiescent cells with homozygous genetic mutations in p16
M. Aghi et al.
ONCOGENE (2008)
Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis
Thi Lien-Anh Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities
Stefan Diermayr et al.
BLOOD (2008)
Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide
R. M. Myers et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Acetylation-dependent signal transduction for type I interferon receptor
Xiaoli Tang et al.
CELL (2007)
The PP2A inhibitor SET regulates natural killer cell IFN-γ production
Rossana Trotta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses
Giulia Fulci et al.
CANCER RESEARCH (2007)
Coadministration of a herpes simplex virus-2-based oncolytic virus and cyclophosphamide produces a synergistic antitumor effect and enhances tumor-specific immune responses
Hongtao Li et al.
CANCER RESEARCH (2007)
Histone deacetylase inhibitors suppress natural killer cell cytolytic activity
Henry Ogbomo et al.
FEBS LETTERS (2007)
The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention
John P. Alao
MOLECULAR CANCER (2007)
NKp30-dependent cytolysis of filovirus-infected human dendritic cells
Claudette L. Fuller et al.
CELLULAR MICROBIOLOGY (2007)
Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46
Thierry Walzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
Giulia Fulci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Histone deacetylase inhibitors in cancer therapy
Maryam Fouladi
CANCER INVESTIGATION (2006)
Pro- and antiinflammatory cytokine signaling: Reciprocal antagonism regulates interferon-gamma production by human natural killer cells
Jianhua Yu et al.
IMMUNITY (2006)
Positive and negative regulation of the innate antiviral response and beta interferon gene expression by deacetylation
I Nusinzon et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Cyclin D1: polymorphism, aberrant splicing and cancer risk
KE Knudsen et al.
ONCOGENE (2006)
Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme
AI Freeman et al.
MOLECULAR THERAPY (2006)
Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitment
SH Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Cyclophosphamide allows for in vivo dose reduction of a potent oncolytic virus
H Kambara et al.
CANCER RESEARCH (2005)
Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B
S Skov et al.
CANCER RESEARCH (2005)
Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D Ligands by the histone deacetylase inhibitor sodium valproate
S Armeanu et al.
CANCER RESEARCH (2005)
An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor
H Kambara et al.
CANCER RESEARCH (2005)
Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme
C Giannini et al.
NEURO-ONCOLOGY (2005)
Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-κB/p65 DNA binding
J Hu et al.
MOLECULAR CANCER RESEARCH (2005)
Natural killer cell-dendritic cell crosstalk in the initiation of immune responses
T Walzer et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
Altered expression of antiviral cytokine mRNAs associated with cyclophosphamide's enhancement of viral oncolysis
H Wakimoto et al.
GENE THERAPY (2004)
Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity
HM Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival
S Harrow et al.
GENE THERAPY (2004)
A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting
EA Chiocca et al.
MOLECULAR THERAPY (2004)
Impairment of interferon-induced IRF-7 gene expression due to inhibition of ISGF3 formation by trichostatin A
P Génin et al.
JOURNAL OF VIROLOGY (2003)
The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study
V Papanastassiou et al.
GENE THERAPY (2002)
Histone deacetylases and cancer: Causes and therapies
PA Marks et al.
NATURE REVIEWS CANCER (2001)
Amplification of transgene expression in vitro and in vivo using a novel inhibitor of histone deacetylase
T Yamano et al.
MOLECULAR THERAPY (2000)
Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma
R Rampling et al.
GENE THERAPY (2000)
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial
JM Markert et al.
GENE THERAPY (2000)
Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant
K Ikeda et al.
JOURNAL OF VIROLOGY (2000)
分享论文
